Low
solubility and chemical instability are the main
problems with
insoluble bioactives. Lignin, with its exceptional biological properties
and amphiphilicity, holds promise as a delivery system material. In
this study, glycerol esters were incorporated into alkali lignin (AL)
through ether and ester bonds, resulting in the successful synthesis
of three hydrophobically modified alkali lignins (AL-OA, AL-OGL, and
AL-SAN-OGL). Subsequently, lignin composite nanoparticles (LNPs@BC)
encapsulating β-carotene were prepared using antisolvent and
sonication techniques. The encapsulation rates were determined to
be 37.69 ± 2.21%, 84.01 ± 5.55%, 83.82 ± 5.23%, and
83.11 ± 5.85% for LNP@BC-1, LNP@BC-2, LNP@BC-3, and LNP@BC-4,
respectively, with AL, AL-OA, AL-OGL, and AL-SAN-OGL serving as the
wall materials under optimized preparation conditions. The antioxidant
properties and UV-absorbing capacity of the four lignins were characterized,
demonstrating their efficacy in enhancing the oxygen and photostability
of β-carotene. Following 6 h of UV irradiation, LNP@BC-4 exhibited
a retention rate of 83.03 ± 2.85% for β-carotene, while
storage under light-protected conditions at 25 °C for 7 days
retained 73.33 ± 7.62% of β-carotene. Furthermore, the
encapsulated β-carotene demonstrated enhanced thermal and storage
stability. In vitro release experiments revealed superior stability
of LNPs@BC in simulated gastric fluid (SGF), with β-carotene
retention exceeding 77% in both LNP@BC-3 and LNP@BC-4. LNP@BC-4 exhibited
the highest bioaccessibility in simulated intestinal fluid (SIF) at
46.96 ± 0.80%, that LNP@BC-1 only achieved 10.87 ± 0.90%.
The enzymatic responsiveness of AL-OGL and AL-SAN-OGL was confirmed.
Moreover, LNPs@BC exhibited no cytotoxicity toward L929 cells and
demonstrated excellent hemocompatibility. In summary, this study introduces
a novel enzyme-responsive modified lignin that has promising applications
in the fields of food, biomedicine, and animal feed.